Meitav Dash Investments Ltd. lifted its position in National Health Investors Inc (NYSE:NHI) by 24.5% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,219 shares of the real estate investment trust’s stock after acquiring an additional 4,170 shares during the quarter. Meitav Dash Investments Ltd.’s holdings in National Health Investors were worth $1,289,000 at the end of the most recent reporting period.
Other hedge funds have also recently added to or reduced their stakes in the company. M&T Bank Corp lifted its position in shares of National Health Investors by 102.8% during the first quarter. M&T Bank Corp now owns 5,148 shares of the real estate investment trust’s stock worth $254,000 after purchasing an additional 2,609 shares during the last quarter. BNP Paribas Arbitrage SA lifted its holdings in National Health Investors by 282.0% during the 1st quarter. BNP Paribas Arbitrage SA now owns 36,604 shares of the real estate investment trust’s stock valued at $1,813,000 after buying an additional 27,022 shares in the last quarter. Guggenheim Capital LLC boosted its position in National Health Investors by 17.6% in the 1st quarter. Guggenheim Capital LLC now owns 19,661 shares of the real estate investment trust’s stock valued at $974,000 after buying an additional 2,936 shares during the period. Nisa Investment Advisors LLC grew its stake in National Health Investors by 29.6% in the 2nd quarter. Nisa Investment Advisors LLC now owns 21,445 shares of the real estate investment trust’s stock worth $1,302,000 after acquiring an additional 4,897 shares in the last quarter. Finally, PNC Financial Services Group Inc. increased its position in shares of National Health Investors by 4.4% during the first quarter. PNC Financial Services Group Inc. now owns 11,897 shares of the real estate investment trust’s stock worth $590,000 after acquiring an additional 496 shares during the period. 68.92% of the stock is owned by hedge funds and other institutional investors.
NHI traded up $1.57 on Thursday, hitting $62.45. The company had a trading volume of 14,360 shares, compared to its average volume of 246,919. The stock has a market capitalization of $2.79 billion, a price-to-earnings ratio of 14.58 and a beta of 0.83. The company has a debt-to-equity ratio of 1.03, a quick ratio of 13.20 and a current ratio of 13.20. The stock has a fifty day moving average price of $61.06 and a 200-day moving average price of $62.02. National Health Investors Inc has a 12-month low of $31.37 and a 12-month high of $91.12.
National Health Investors (NYSE:NHI) last issued its quarterly earnings data on Monday, August 10th. The real estate investment trust reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.44). National Health Investors had a return on equity of 12.74% and a net margin of 57.44%. The firm had revenue of $84.17 million during the quarter, compared to analysts’ expectations of $83.11 million. During the same period in the previous year, the firm earned $1.36 EPS. The firm’s quarterly revenue was up 7.8% on a year-over-year basis. Analysts forecast that National Health Investors Inc will post 5.61 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th were issued a dividend of $1.102 per share. The ex-dividend date of this dividend was Monday, June 29th. This represents a $4.41 annualized dividend and a dividend yield of 7.06%. National Health Investors’s dividend payout ratio is presently 80.18%.
Several research analysts recently issued reports on NHI shares. Zacks Investment Research cut National Health Investors from a “hold” rating to a “sell” rating in a research note on Wednesday, July 29th. Wells Fargo & Co increased their price target on National Health Investors from $54.00 to $66.00 and gave the stock an “equal weight” rating in a research report on Wednesday, June 17th. SunTrust Banks lifted their price objective on National Health Investors from $61.00 to $64.00 and gave the company a “hold” rating in a report on Wednesday, June 24th. JMP Securities started coverage on shares of National Health Investors in a report on Monday, June 8th. They set a “market perform” rating on the stock. Finally, Mizuho lowered shares of National Health Investors from a “buy” rating to a “neutral” rating and reduced their price target for the company from $60.00 to $55.00 in a report on Friday, May 22nd. Three investment analysts have rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. National Health Investors has a consensus rating of “Hold” and a consensus target price of $66.83.
National Health Investors Profile
Incorporated in 1991, National Health Investors, Inc (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent, assisted and memory care communities, entrance-fee retirement communities, skilled nursing facilities, medical office buildings and specialty hospitals.
Further Reading: How to find the components of the quick ratio
Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.